[Medicamentous agranulocytosis as a manifestation of drug induced disease].
D000328:Adult; D000380:Agranulocytosis / Q000139:chemically induced* / Q000473:pathology; D000632:Aminopyrine / Q000009:adverse effects; D001241:Aspirin / Q000009:adverse effects; D002701:Chloramphenicol / Q000009:adverse effects; D064420:Drug-Related Side Effects and Adverse Reactions; D004947:Esophagus / Q000473:pathology; D005260:Female; D006801:Humans; D007422:Intestines / Q000473:pathology; D008297:Male; D008620:Meprobamate / Q000009:adverse effects; D008875:Middle Aged; D010406:Penicillins / Q000009:adverse effects; D010653:Phenylbutazone / Q000009:adverse effects; D013424:Sulfanilamides; D013752:Tetracycline / Q000009:adverse effects
D010406:Penicillins; D013424:Sulfanilamides; D000632:Aminopyrine; D002701:Chloramphenicol; D008620:Meprobamate; D013752:Tetracycline; D010653:Phenylbutazone; D001241:Aspirin
Medikamentoznye agranulotsitozy kak proiavleniia lekarstvennoĭ bolezni